Amino Acid Levels as Potential Biomarker of Elderly Patients with Dementia

Dementia is a clinical syndrome characterized by cognitive impairment, in which there is disturbance of multiple higher cortical functions. The primary risk factor of dementia is old age, and due to significant changes in the worldwide demographic structure, the prevalence of cognitive impairment is...

Full description

Bibliographic Details
Main Authors: Edyta Socha, Piotr Kośliński, Marcin Koba, Katarzyna Mądra-Gackowska, Kornelia Kędziora-Kornatowska, Marcin Gackowski, Emilia Daghir-Wojtkowiak
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/10/12/914
id doaj-38a43c2bc5fa40249176ea94fdea45b2
record_format Article
spelling doaj-38a43c2bc5fa40249176ea94fdea45b22020-11-28T00:02:18ZengMDPI AGBrain Sciences2076-34252020-11-011091491410.3390/brainsci10120914Amino Acid Levels as Potential Biomarker of Elderly Patients with DementiaEdyta Socha0Piotr Kośliński1Marcin Koba2Katarzyna Mądra-Gackowska3Kornelia Kędziora-Kornatowska4Marcin Gackowski5Emilia Daghir-Wojtkowiak6Department of Toxicology and Bromatology, Faculty of Pharmacy, Collegium Medicum of Nicolaus Copernicus University, 85-067 Bydgoszcz, PolandDepartment of Toxicology and Bromatology, Faculty of Pharmacy, Collegium Medicum of Nicolaus Copernicus University, 85-067 Bydgoszcz, PolandDepartment of Toxicology and Bromatology, Faculty of Pharmacy, Collegium Medicum of Nicolaus Copernicus University, 85-067 Bydgoszcz, PolandDepartment of Geriatrics, Faculty of Health Sciences, Collegium Medicum of Nicolaus Copernicus University, 85-067 Bydgoszcz, PolandDepartment of Geriatrics, Faculty of Health Sciences, Collegium Medicum of Nicolaus Copernicus University, 85-067 Bydgoszcz, PolandDepartment of Toxicology and Bromatology, Faculty of Pharmacy, Collegium Medicum of Nicolaus Copernicus University, 85-067 Bydgoszcz, PolandDepartment of Biopharmaceutics and Pharmacodynamics, Medical University of Gdańsk, 80-210 Gdańsk, PolandDementia is a clinical syndrome characterized by cognitive impairment, in which there is disturbance of multiple higher cortical functions. The primary risk factor of dementia is old age, and due to significant changes in the worldwide demographic structure, the prevalence of cognitive impairment is increasing dramatically with aging populations in most countries. Alzheimer’s disease is the predominant and leading cause of dementia. The aim of this study was to evaluate the modifications of amino acids that characterize the initial stages of dementia to help our understanding of the complex and multifactorial pathogenesis of neurodegenerative disorders. A total of 123 participants were divided into two groups: healthy elderly subjects and patients with mild or moderate dementia. The results of this study indicate that the serum levels of three amino acids were changed significantly in patients with dementia, in relation to the subjects without dementia. In particular, we observed differences in concentrations for serine, arginine and isoleucine (all of them were significantly increased in patients with dementia, compared with the control group). Our results suggest that the metabolisms of some amino acids seem be changed in patients with dementia. We conclude that amino acid profiling might be helpful for the better understanding of biochemical and metabolic changes related to the pathogenesis and progression of dementia. However, considering the multifactorial, heterogenous and complex nature of this disease, validation with a greater study sample in further research is required.https://www.mdpi.com/2076-3425/10/12/914neurodegenerative diseasesmild dementiamoderate dementiaamino acidsarginineserine
collection DOAJ
language English
format Article
sources DOAJ
author Edyta Socha
Piotr Kośliński
Marcin Koba
Katarzyna Mądra-Gackowska
Kornelia Kędziora-Kornatowska
Marcin Gackowski
Emilia Daghir-Wojtkowiak
spellingShingle Edyta Socha
Piotr Kośliński
Marcin Koba
Katarzyna Mądra-Gackowska
Kornelia Kędziora-Kornatowska
Marcin Gackowski
Emilia Daghir-Wojtkowiak
Amino Acid Levels as Potential Biomarker of Elderly Patients with Dementia
Brain Sciences
neurodegenerative diseases
mild dementia
moderate dementia
amino acids
arginine
serine
author_facet Edyta Socha
Piotr Kośliński
Marcin Koba
Katarzyna Mądra-Gackowska
Kornelia Kędziora-Kornatowska
Marcin Gackowski
Emilia Daghir-Wojtkowiak
author_sort Edyta Socha
title Amino Acid Levels as Potential Biomarker of Elderly Patients with Dementia
title_short Amino Acid Levels as Potential Biomarker of Elderly Patients with Dementia
title_full Amino Acid Levels as Potential Biomarker of Elderly Patients with Dementia
title_fullStr Amino Acid Levels as Potential Biomarker of Elderly Patients with Dementia
title_full_unstemmed Amino Acid Levels as Potential Biomarker of Elderly Patients with Dementia
title_sort amino acid levels as potential biomarker of elderly patients with dementia
publisher MDPI AG
series Brain Sciences
issn 2076-3425
publishDate 2020-11-01
description Dementia is a clinical syndrome characterized by cognitive impairment, in which there is disturbance of multiple higher cortical functions. The primary risk factor of dementia is old age, and due to significant changes in the worldwide demographic structure, the prevalence of cognitive impairment is increasing dramatically with aging populations in most countries. Alzheimer’s disease is the predominant and leading cause of dementia. The aim of this study was to evaluate the modifications of amino acids that characterize the initial stages of dementia to help our understanding of the complex and multifactorial pathogenesis of neurodegenerative disorders. A total of 123 participants were divided into two groups: healthy elderly subjects and patients with mild or moderate dementia. The results of this study indicate that the serum levels of three amino acids were changed significantly in patients with dementia, in relation to the subjects without dementia. In particular, we observed differences in concentrations for serine, arginine and isoleucine (all of them were significantly increased in patients with dementia, compared with the control group). Our results suggest that the metabolisms of some amino acids seem be changed in patients with dementia. We conclude that amino acid profiling might be helpful for the better understanding of biochemical and metabolic changes related to the pathogenesis and progression of dementia. However, considering the multifactorial, heterogenous and complex nature of this disease, validation with a greater study sample in further research is required.
topic neurodegenerative diseases
mild dementia
moderate dementia
amino acids
arginine
serine
url https://www.mdpi.com/2076-3425/10/12/914
work_keys_str_mv AT edytasocha aminoacidlevelsaspotentialbiomarkerofelderlypatientswithdementia
AT piotrkoslinski aminoacidlevelsaspotentialbiomarkerofelderlypatientswithdementia
AT marcinkoba aminoacidlevelsaspotentialbiomarkerofelderlypatientswithdementia
AT katarzynamadragackowska aminoacidlevelsaspotentialbiomarkerofelderlypatientswithdementia
AT korneliakedziorakornatowska aminoacidlevelsaspotentialbiomarkerofelderlypatientswithdementia
AT marcingackowski aminoacidlevelsaspotentialbiomarkerofelderlypatientswithdementia
AT emiliadaghirwojtkowiak aminoacidlevelsaspotentialbiomarkerofelderlypatientswithdementia
_version_ 1724413234239242240